We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

First Biological Implants Used for Treatment of Cartilage Lesions and Osteoarthritis in Humans

By HospiMedica International staff writers
Posted on 21 Nov 2023
Print article
Image: The N-TEC procedure offers an alternative to cure confined knee cartilage lesions and address degenerative OA (Photo courtesy of 123RF)
Image: The N-TEC procedure offers an alternative to cure confined knee cartilage lesions and address degenerative OA (Photo courtesy of 123RF)

Every year, millions of joint replacement surgeries take place, and even more patients seek alternatives to delay or avoid using prostheses. An exciting new procedure now offers a promising solution for treating localized knee cartilage lesions and degenerative osteoarthritis (OA) cases, traditionally managed with knee joint replacements that typically require replacement after 15-20 years.

At the University Hospital Basel (Basel, Switzerland), researchers are pioneering a method that uses chondrocytes, the fundamental cells for cartilage construction, to grow new cartilage. This development could offer a significant alternative for patients who need more than just pain management but are reluctant to opt for a prosthetic joint. The procedure, named Nasal Chondrocyte Tissue-Engineered Cartilage (N-TEC), leverages autologous (self-derived) cartilage cells to create new cartilage grafts. These are then surgically implanted to repair the damaged cartilage in patients' joints. The process involves taking a small cartilage sample from the patient’s nasal septum, cultivating and expanding these cells, and then using them to grow new nasal cartilage grafts up to 40 cm2 on a collagen membrane. Remarkably, this process takes only four weeks, and harvesting the cartilage does not harm the patient's nose.

A key aspect of this technique is the use of nasal cartilage, which consists of neural crest-derived cells known for their high regenerative capacity and adaptability to various environments. This makes nasal chondrocytes, particularly from older donors, ideal for engineering N-TEC cartilage patches with the structural and mechanical qualities of typical articular cartilage tissues. Beyond lab and animal trials, N-TEC has successfully moved into clinical application. The University of Basel’s team, leading a multi-center trial across Europe, has effectively treated over 100 patients with knee focal lesions since 2012. The N-TEC grafts, tailored to the specific size and shape of the cartilage defect, are implanted via open surgery, where they integrate with surrounding cartilage and subchondral bone.

Not limited to focal lesions, the technique has been applied to patients with advanced knee OA, traditionally slated for joint replacement surgery. Two patients treated with N-TEC, along with leg axis correction, have reported sustained positive outcomes and continue to engage in daily activities six years after the procedure, without needing artificial joint replacements. Building on this success, the University Hospital Basel team is now extending this approach to treat OA and cartilage defects in various joints. They are conducting clinical trials focused on Patella-Femoral OA in the knee and cartilage issues in the ankle and shoulder, with plans to start elbow joint trials in 2024.

“N-TEC has demonstrated overwhelming success in human clinical studies to date,” said Ivan Martin, PhD, Professor of Tissue Engineering at the Department of Biomedicine, University of Basel and University Hospital Basel. “Thanks to generous public funding and cooperation with other outstanding teams, we will now extend clinical trials to investigate N-TEC in more challenging conditions so that someday it can become a mainstream bed-side procedure for many patients suffering from joint pain induced by cartilage loss.”

Related Links:
University Hospital Basel 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Eye-Level Digital Physician Scale

Print article


Critical Care

view channel
Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)

Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions

The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.